NCT02774863

Brief Summary

Emotional Neglect (NE) is a form of abuse to the child whose prevalence is high (WHO Europe). Experiencing NE, psycho-emotional development and brain child may be impacted generating psychic suffering signs may progress to severe developmental disorders. The recognition of suffering can prevent and treat these disorders. This research promotes a multi-professional device, centered on observation, collection of expression of the baby's psychic pain (≤ 2 years) living in vulnerable families. The investigators assume that this collection requires the crossing of looks of a child psychiatrist and a repeated observation at home by a trained nurse. The two devices described in these two groups are devices set up as part of the routine management of these patients. Usually, depending on the means of structures (human and financial), one of these devices may be preferred over another.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2016

Shorter than P25 for all trials

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 17, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

November 23, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2017

Completed
Last Updated

August 9, 2017

Status Verified

August 1, 2017

Enrollment Period

7 months

First QC Date

May 11, 2016

Last Update Submit

August 8, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of the sensitivity of the Global Printing-scale gravity relative to the Development Quotient (reference) between the 2 supported (Group A versus Group B).

    Development Quotient level will be measured by Brunet Lezine R. This questionnaire provides an objective measure of the impact of mental suffering. It will be measured by psychomotor between the 3rd and 4th month follow up. A child with a score of QD lower or equal 85 is considered a child with developmental impairment. \- Clinical Global Impression Severity Scale suitable for measuring the assessment of mental suffering of children less than two years is considered an indicator of the intensity of suffering. This will be assessed by a nurse between the 3rd and 4th months of follow up. A child with a CGI-severity score between 1 and 4 inclusive shall be considered a child with developmental impairment.

    up to three months

Study Arms (2)

Group "Maternal and Child Protection"

Followed by the doctor and pediatric nurse of the Maternal and Child Protection . A child psychiatric consultation (usual care) can take place during the monitoring of this patient.

Group "Home passages"

A child psychiatric consultation is scheduled in the month following the inclusion and three home passages between the 2nd and 3rd months of follow up.

Other: Home passages

Interventions

Three home passages between the 2nd and 3rd months of follow up.

Group "Home passages"

Eligibility Criteria

Age1 Year - 24 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Fifty children and their families (parents / guardians) will be included in the research in the department of Loire-Atlantique, coming visit to the Mother and Child Protection within the first two years of their child.

You may qualify if:

  • Families say vulnerable falling M.Heaman selection criteria associated with two significant items of Q-Sort, agreeing to participate in the research project.
  • Patient 24 months or less at the time of the first consultation PMI.
  • Parents / legal representatives agreeing to participate in the research project.
  • Serious genetic and somatic pathologies resulting deficiency, physical pain,
  • Non-French speaking families.
  • Families whose baby is monitored as part of the network grow together because of their prematurity.
  • Minor or major Parents Trust

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Medical-social Center Dalby Millet

Nantes, 44000, France

Location

Medical-Social center Bellevue

Nantes, 44100, France

Location

Medical-social center Pilotière

Nantes, 44300, France

Location

Medical-Social center Port Boyer

Nantes, 44300, France

Location

Medical-social St-Etienne de Montluc

Saint-Étienne-de-Montluc, 44360, France

Location

Medical-social Saint-Servan

Saint-Herblain, 44800, France

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2016

First Posted

May 17, 2016

Study Start

November 23, 2016

Primary Completion

July 5, 2017

Study Completion

July 5, 2017

Last Updated

August 9, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations